JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: LY294002, a morpholine-containing compound designed based on the flavonoid quercetin, is a potent and cell-permeable PI3K inhibitor, inhibiting PI3Kalpha/delta/beta with IC50 of 0.5 uM/0.57 uM/0.97 uM in cell-free assays, respectively. It is also an inhibitor of BET (e.g. of BRD2, BRD3, and BRD4). In solution, it is more stable than Wortmannin (PI3K inhibitor). LY294002 is selective against p110alpha, p110beta, p110gamma and p110delta, by acting on the ATP binding site of the catalytic subunit of PI3K.
References: J Biol Chem. 1994 Feb 18; 269(7):5241-8; Biochem J. 2007 Jun 15; 404(3):449-58.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!